Anogenital distance and the risk of Late-onset hypogonadism
This work adds to the scientific evidence that AGD-a biomarker of fetal exposure-could provide a non-invasive measure to address LOH, providing a potential useful clinical tool.
Authors
- Miriam Artés Artés (ORCID: https://orcid.org/0000-0001-5687-5605)
- Emny Rochell Bobadilla Romero (ORCID: https://orcid.org/0000-0003-3191-2806)
- Pablo Guzmán (ORCID: https://orcid.org/0000-0001-5847-7248)
- Víctor Javier García-Porcel (ORCID: https://orcid.org/0000-0001-8979-2937)
- Florencio Manuel Marín-Martínez (ORCID: https://orcid.org/0000-0002-4387-2525)
- Mabel Coromoto Suárez-Pineda (ORCID: https://orcid.org/0000-0001-5958-5806)
- Julián J. Árense-Gonzalo (ORCID: https://orcid.org/0000-0002-9801-1060)
- Jaime Mendiola (ORCID: https://orcid.org/0000-0002-0657-9346)
Institutions
- Instituto de Salud Carlos III (ES)
- Hospital de Hellín (ES)
- Hospital Reina Sofía de Murcia (ES)
- Santa Lucía University General Hospital (ES)
- Instituto Murciano de Investigación Biosanitaria (ES)
- Hospital Universitario Virgen de la Arrixaca (ES)
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES)
- Universidad de Murcia (ES)
Publication Details
- Journal
- Urologia Journal
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1177/03915603241287881
- Primary Topic
- Sexual Differentiation and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00